Enhancing Primaquine Adherence for Plasmodium vivax Malaria: A Cluster-Randomized Controlled Trial in Myanmar

Kyawt Mon Win Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;
Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;
Department of Public Health, Ministry of Health, Naypyidaw, Myanmar;

Search for other papers by Kyawt Mon Win in
Current site
Google Scholar
PubMed
Close
,
Pyae Linn Aung Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;

Search for other papers by Pyae Linn Aung in
Current site
Google Scholar
PubMed
Close
,
Nay Yi Yi Linn Department of Public Health, Ministry of Health, Naypyidaw, Myanmar;

Search for other papers by Nay Yi Yi Linn in
Current site
Google Scholar
PubMed
Close
,
Zau Ring State Public Health Department, Kachin, Myanmar;

Search for other papers by Zau Ring in
Current site
Google Scholar
PubMed
Close
,
Myat Phone Kyaw Myanmar Health Network Organization, Yangon, Myanmar;

Search for other papers by Myat Phone Kyaw in
Current site
Google Scholar
PubMed
Close
,
Wang Nguitragool Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;
Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; and

Search for other papers by Wang Nguitragool in
Current site
Google Scholar
PubMed
Close
,
Liwang Cui Division of Infectious Diseases and International Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida

Search for other papers by Liwang Cui in
Current site
Google Scholar
PubMed
Close
,
Jetsumon Sattabongkot Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;

Search for other papers by Jetsumon Sattabongkot in
Current site
Google Scholar
PubMed
Close
, and
Saranath Lawpoolsri Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;

Search for other papers by Saranath Lawpoolsri in
Current site
Google Scholar
PubMed
Close

The rising prevalence of Plasmodium vivax (P. vivax) malaria challenges elimination efforts, particularly in the Greater Mekong Subregion, although adherence to the required 14-day primaquine (PQ) regimen remains a major obstacle. This study evaluated the effectiveness of a family-administered, directly observed treatment intervention in improving adherence to PQ among patients with confirmed P. vivax from October 2022 to March 2023. A cluster-randomized controlled trial was conducted in five intervention villages and five control villages in Kachin State, Myanmar. A total of 427 patients in the intervention group (supervised dosing) and 425 patients in the control group (unsupervised dosing), all diagnosed with P. vivax, underwent a 14-day PQ regimen, with the intervention group being supervised by trained family members. Pill counts on day 14 were assessed and compared between the two groups using Poisson generalized linear mixed models. Parasite reappearance identified by polymerase chain reaction was compared between the two groups using survival analysis. Cumulative malaria incidence at baseline, as well as at months 6 and 12, was compared between the two groups. Treatment adherence was significantly higher in the intervention group (98.8%) compared with the control group (77.6%). Parasite reappearance rates were similar between the groups (P = 0.20) on days 14, 28, and 42. However, the cumulative incidence of malaria over 1 year was significantly lower in the intervention group (P <0.001) compared with the control group. In malaria-endemic areas with limited resources, a family-administered, directly observed treatment intervention offers an efficient approach to enhance PQ adherence and achieve the radical cure of P. vivax malaria.

Author Notes

Financial support: This research was funded by the National Institute of Allergy and Infectious Diseases, NIH, USA (U19AI089672). Open access funding provided by Mahidol University.

Disclosure: The study protocol was approved by the Institutional Review Board of the University of Public Health, Yangon, Myanmar (UPH-IRB: 2022/Research/6), and the Ethics Committee for Human Research Study, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand (MUTM 2022–064-01). Participants were informed about the study and signed consent forms before participating. Informed consent was obtained from the parents or legal guardians if participants were under 18 years old.

Current contact information: Kyawt Mon Win, Pyae Linn Aung, Wang Nguitragool, and Jetsumon Sattabongkot, Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, E-mails: kyawtmonwin@gmail.com, pyaelinn.aun@mahidol.ac.th, wang.ngu@mahidol.edu, and jetsumon.pra@mahidol.edu. Nay Yi Yi Linn, Department of Public Health, Ministry of Health, Naypyidaw, Myanmar, E-mail: centralnmcp@gmail.com. Zau Ring, State Public Health Department, Kachin, Myanmar, E-mail: zauring.kachinsphd@gmail.com. Myat Phone Kyaw, Myanmar Health Network Organization, Yangon, Myanmar, E-mail: kyaw606@gmail.com. Liwang Cui, Division of Infectious Diseases and International Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, E-mail: liwangcui@usf.edu. Saranath Lawpoolsri, Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, E-mail: saranath.law@mahidol.ac.th.

Address correspondence to Saranath Lawpoolsri, Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand. E-mail: saranath.law@mahidol.ac.th
Past two years Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 167 167 167
PDF Downloads 132 132 132
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save